Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RWJBarnabas Health is New Jersey's largest and most comprehensive academic healthcare system, formed by the 2016 merger of Robert Wood Johnson Health System and Barnabas Health. The system operates a vast network of facilities, including 12 acute care hospitals, three children's hospitals, and numerous outpatient centers, serving over five million patients annually. Through its deep integration with Rutgers University, RWJBarnabas Health functions as a premier site for clinical research and medical education, particularly in oncology, cardiology, and transplantation. The organization is home to the Rutgers Cancer Institute of New Jersey, the state's only NCI-designated Comprehensive Cancer Center, and maintains one of the largest renal transplant programs in the United States. Its flagship facilities are recognized for pioneering work in robotic surgery, precision medicine, and advanced maternal-fetal care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Saint Barnabas.